Skip to content

Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00209885
Enrollment
60
Registered
2005-09-21
Start date
2005-10-31
Completion date
Unknown
Last updated
2005-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystolithiasis

Brief summary

To test the current standard of care (SOC) treatment for laparoscopic cholecystectomy with a group receiving SOC + additional perioperative analgesics in terms of postoperative abilities, PONV, pain and discharge time from the PACU

Detailed description

Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups: * A: standard of care (SOC)receiving intraoperative dexamethasone, ondansetron, ketorolac, and general anaesthesia with propofol, remifentanil and cisatracurium * B: SOC + preoperative gabapentin, intraoperative lidocain infusion, s-ketamin and droperidol. Primary endpoints: * postoperative abilities over time * discharge time from PACU according to fixed criteria * consumption of analgesics and antiemetics in the PACU Secondary endpoints: * degree of nursing requirements at the PACU * General tolerability of the regimes

Interventions

DRUGGabapentin
DRUGS-ketamine
DRUGLidocaine

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective laparoscopic cholecystectomy * Age above 18 years * Written informed consent * ASA class I-III

Exclusion criteria

* Planned abdominal cholecystectomy * Intraoperative conversion of laparoscopic to laparotomic cholecystectomy * Allergy to part of the treatment regimens * Previous reactions to opioids (nausea, cognition)

Design outcomes

Primary

MeasureTime frame
1. postoperative abilities over time in PACU
2. discharge time from PACU according to fixed criteria
3. consumption of analgesics and antiemetics in the PACU

Secondary

MeasureTime frame
1. Degree of nursing requirements in the PACU
2. General tolerability of the regimens

Countries

Denmark

Contacts

Primary ContactKenneth Jensen, M.D.
kenneth.jensen@hh.hosp.dk+45 36 32 62 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026